BRIEF published on 06/04/2026 at 07:36, 3 months 7 days ago Sword Group Secures €93 Million eu-LISA Contract Sword Group EU Entry/Exit System Eu-LISA Contract Border Management Security And Efficiency
BRIEF published on 06/04/2026 at 07:36, 3 months 7 days ago Sword Group secures a strategic contract with eu-LISA Sword Group Eu-LISA Entrances And Exits Contract Worth Millions Of Euros Border Security
PRESS RELEASE published on 06/04/2026 at 07:31, 3 months 7 days ago Sword Group: Strategic contract with eu-LISA Sword Group led consortium wins €93 million EU Entry/Exit System contract under eu-LISA framework, reinforcing position as trusted partner for European institutions Contract Sword Group EU Entry/Exit System Eu-LISA Framework European Institutions
PRESS RELEASE published on 06/04/2026 at 07:31, 3 months 7 days ago Sword Group : Contrat stratégique avec eu-LISA Sword Group remporte contrat de 93 millions d’euros pour le système européen de gestion des entrées et sorties eu-LISA, renforçant la sécurité et la fluidité des frontières Contrat Sécurité Sword Group Eu-LISA Gestion Frontières
BRIEF published on 01/22/2026 at 19:26, 7 months 19 days ago Sword Group Reports Solid Q4 2025 Financial Results Financial Results EBITDA Margin Organic Growth Sword Group Q4 2025
BRIEF published on 01/22/2026 at 19:26, 7 months 19 days ago Sword Group annonce de solides résultats financiers pour le quatrième trimestre 2025. Résultats Financiers Croissance Organique Marge D'EBITDA Groupe D'épées 4e Trimestre 2025
BRIEF published on 01/22/2026 at 19:26, 7 months 19 days ago Sword Group : Bilan du 4ème Trimestre 2025 EBITDA Croissance Organique Backlog Sword Group Finances 2025
BRIEF published on 01/22/2026 at 19:26, 7 months 19 days ago Sword Group: Q4 2025 Review EBITDA Organic Growth Backlog Sword Group Finances 2025
PRESS RELEASE published on 01/22/2026 at 19:21, 7 months 19 days ago Sword Group | Q4 2025 Results Sword Group announces Q4 2025 results with consolidated revenue of €90.8m (+12.2% organic growth) and EBITDA margin of 12.0%. 2026 outlook includes 12% organic growth target EBITDA Margin Organic Growth Sword Group 2026 Outlook Q4 2025
PRESS RELEASE published on 01/22/2026 at 19:21, 7 months 19 days ago Sword Group | Résultats du 4ème Trimestre 2025 Sword Group annonce des résultats financiers solides avec une croissance organique de +12,2% au T4 2025 et une marge d'EBITDA de 12,0%. Le chiffre d'affaires consolidé est de 90,8 M€ Chiffre D'affaires Résultats Financiers Croissance Organique Marge D'EBITDA Sword Group
Published on 09/11/2026 at 04:00, 6 hours 38 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 13 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 18 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 38 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 22 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 17 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 32 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 38 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 8 minutes ago Availability of the 2026 Interim Financial Report
